Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple DAAs for Non-cirrhotic Chronic HCV G1b Infection
NCT02470858Phase 2Completed
- Sponsor
- Humanity & Health Research Centre
- Start
- Jan 2015
- Primary completion
- Dec 2015
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of asunaprevir, simeprevir, sofosbuvir, daclatasvir, ledipasvir in hepatitis C (HCV), sponsored by Humanity & Health Research Centre. Started Jan 2015; status: completed.
02
Drugs
asunaprevirsimeprevirsofosbuvirdaclatasvirledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02470858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02470858.